134 related articles for article (PubMed ID: 34039686)
1. Diabetic Polyneuropathy Early in Type 2 Diabetes Is Associated With Higher Incidence Rate of Cardiovascular Disease: Results From Two Danish Cohort Studies.
Bjerg L; Nicolaisen SK; Christensen DH; Nielsen JS; Andersen ST; Jørgensen ME; Jensen TS; Sandbæk A; Andersen H; Beck-Nielsen H; Sørensen HT; Witte DR; Thomsen RW; Charles M
Diabetes Care; 2021 Jul; 44(7):1714-1721. PubMed ID: 34039686
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark.
Andersen ST; Witte DR; Dalsgaard EM; Andersen H; Nawroth P; Fleming T; Jensen TM; Finnerup NB; Jensen TS; Lauritzen T; Feldman EL; Callaghan BC; Charles M
Diabetes Care; 2018 May; 41(5):1068-1075. PubMed ID: 29487078
[TBL] [Abstract][Full Text] [Related]
3. Metabolic Factors, Lifestyle Habits, and Possible Polyneuropathy in Early Type 2 Diabetes: A Nationwide Study of 5,249 Patients in the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) Cohort.
Christensen DH; Knudsen ST; Gylfadottir SS; Christensen LB; Nielsen JS; Beck-Nielsen H; Sørensen HT; Andersen H; Callaghan BC; Feldman EL; Finnerup NB; Jensen TS; Thomsen RW
Diabetes Care; 2020 Jun; 43(6):1266-1275. PubMed ID: 32295810
[TBL] [Abstract][Full Text] [Related]
4. Lipid Levels and Risk of Diabetic Polyneuropathy in 2 Danish Type 2 Diabetes Cohorts.
Kristensen FPB; Christensen DH; Callaghan BC; Nielsen JS; Højlund K; Andersen H; Dekkers OM; Groenwold RHH; Sørensen HT; Thomsen RW
Neurology; 2024 Jul; 103(1):e209538. PubMed ID: 38833657
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and prevalence of diabetic polyneuropathy: a cross-sectional study of Danish patients with type 2 diabetes.
Gylfadottir SS; Itani M; Krøigård T; Kristensen AG; Christensen DH; Nicolaisen SK; Karlsson P; Callaghan BC; Bennett DL; Andersen H; Tankisi H; Nielsen JS; Andersen NT; Jensen TS; Thomsen RW; Sindrup SH; Finnerup NB
Eur J Neurol; 2020 Dec; 27(12):2575-2585. PubMed ID: 32909392
[TBL] [Abstract][Full Text] [Related]
6. Risk-Factor Trajectories Preceding Diabetic Polyneuropathy: ADDITION-Denmark.
Andersen ST; Witte DR; Andersen H; Bjerg L; Bruun NH; Jørgensen ME; Finnerup NB; Lauritzen T; Jensen TS; Tankisi H; Charles M
Diabetes Care; 2018 Sep; 41(9):1955-1962. PubMed ID: 29987164
[TBL] [Abstract][Full Text] [Related]
7. Does training of general practitioners for intensive treatment of people with screen-detected diabetes have a spillover effect on mortality and cardiovascular morbidity in 'at risk' individuals with normoglycaemia? Results from the ADDITION-Denmark cluster-randomised controlled trial.
Simmons RK; Bruun NH; Witte DR; Borch-Johnsen K; Jørgensen ME; Sandbæk A; Lauritzen T
Diabetologia; 2017 Jun; 60(6):1016-1021. PubMed ID: 28280901
[TBL] [Abstract][Full Text] [Related]
8. The Prevalence of Polyneuropathy in Type 2 Diabetes Subgroups Based on HOMA2 Indices of β-Cell Function and Insulin Sensitivity.
Kristensen FPB; Christensen DH; Callaghan BC; Stidsen JV; Nielsen JS; Højlund K; Beck-Nielsen H; Jensen TS; Andersen H; Vestergaard P; Jessen N; Olsen MH; Hansen T; Brøns C; Vaag A; Sørensen HT; Thomsen RW
Diabetes Care; 2023 Aug; 46(8):1546-1555. PubMed ID: 37335990
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Change in Serum Neurofilament Light Chain in Type 2 Diabetes and Early Diabetic Polyneuropathy: ADDITION-Denmark.
Määttä LL; Andersen ST; Parkner T; Hviid CVB; Bjerg L; Kural MA; Charles M; Søndergaard E; Kuhle J; Tankisi H; Witte DR; Jensen TS
Diabetes Care; 2024 Jun; 47(6):986-994. PubMed ID: 38502878
[TBL] [Abstract][Full Text] [Related]
10. Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009.
Simmons RK; Griffin SJ; Lauritzen T; Sandbæk A
Diabetologia; 2017 Nov; 60(11):2192-2199. PubMed ID: 28831539
[TBL] [Abstract][Full Text] [Related]
11. Psychological distress, cardiovascular complications and mortality among people with screen-detected type 2 diabetes: follow-up of the ADDITION-Denmark trial.
Dalsgaard EM; Vestergaard M; Skriver MV; Maindal HT; Lauritzen T; Borch-Johnsen K; Witte D; Sandbaek A
Diabetologia; 2014 Apr; 57(4):710-7. PubMed ID: 24442448
[TBL] [Abstract][Full Text] [Related]
12. Screening for diabetic peripheral neuropathy at community pharmacies in Slovakia.
Pagáčová Z; Grofik M; Fazekaš T; Žufková V; Mináriková D
Croat Med J; 2024 Apr; 65(2):85-92. PubMed ID: 38706234
[TBL] [Abstract][Full Text] [Related]
13. The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange.
Mizokami-Stout KR; Li Z; Foster NC; Shah V; Aleppo G; McGill JB; Pratley R; Toschi E; Ang L; Pop-Busui R; ;
Diabetes Care; 2020 Apr; 43(4):806-812. PubMed ID: 32029635
[TBL] [Abstract][Full Text] [Related]
14. Statin Therapy and Risk of Polyneuropathy in Type 2 Diabetes: A Danish Cohort Study.
Kristensen FP; Christensen DH; Callaghan BC; Kahlert J; Knudsen ST; Sindrup SH; Feldman EL; Østergaard L; Andersen H; Jensen TS; Sørensen HT; Thomsen RW
Diabetes Care; 2020 Dec; 43(12):2945-2952. PubMed ID: 32998990
[TBL] [Abstract][Full Text] [Related]
15. Falls and fractures associated with type 2 diabetic polyneuropathy: A cross-sectional nationwide questionnaire study.
Khan KS; Christensen DH; Nicolaisen SK; Gylfadottir SS; Jensen TS; Nielsen JS; Thomsen RW; Andersen H
J Diabetes Investig; 2021 Oct; 12(10):1827-1834. PubMed ID: 33686761
[TBL] [Abstract][Full Text] [Related]
16. Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION-Denmark trial.
Simmons RK; Carlsen AH; Griffin SJ; Charles M; Christiansen JS; Borch-Johnsen K; Sandbaek A; Lauritzen T
Diabet Med; 2014 Dec; 31(12):1577-85. PubMed ID: 25185778
[TBL] [Abstract][Full Text] [Related]
17. Diabetic Peripheral Neuropathy is Associated With Diabetic Kidney Disease and Cardiovascular Disease: The Silesia Diabetes-Heart Project.
Nabrdalik K; Kwiendacz H; Moos J; Moos Ł; Kulpa J; Brzoza Z; Stompór T; Gumprecht J; Lip GYH
Curr Probl Cardiol; 2023 Aug; 48(8):101726. PubMed ID: 36967071
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for the Presence and Progression of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: ADDITION-Denmark.
Andersen ST; Witte DR; Fleischer J; Andersen H; Lauritzen T; Jørgensen ME; Jensen TS; Pop-Busui R; Charles M
Diabetes Care; 2018 Dec; 41(12):2586-2594. PubMed ID: 30305347
[TBL] [Abstract][Full Text] [Related]
19. Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality.
Strelitz J; Ahern AL; Long GH; Hare MJL; Irving G; Boothby CE; Wareham NJ; Griffin SJ
Diabetologia; 2019 Aug; 62(8):1391-1402. PubMed ID: 31062041
[TBL] [Abstract][Full Text] [Related]
20. Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults.
Simmons RK; Griffin SJ; Witte DR; Borch-Johnsen K; Lauritzen T; Sandbæk A
Diabetologia; 2017 Nov; 60(11):2183-2191. PubMed ID: 28831535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
